Correvio Pharma (CORV) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2020. This widely-known consensus outlook ...
Correvio Pharma Corp.'s (TSE:CORV): Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. With the latest financial year loss of -US$16.6m and a ...
Investors are always looking for growth in small-cap stocks like Correvio Pharma Corp (TSX:CORV), with a market cap of CA$105.66M. However, an important fact which most ignore is: how financially ...
In a recent study posted to the bioRxiv* preprint server, researchers assessed the immune responses induced by two doses or three doses of the BNT162b2 (BNT) vaccine or the CoronaVac (CorV) vaccine ...
VANCOUVER, Aug. 12, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that an abstract ...
This company is not actively trading or the ticker does belong to another company in our database now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results